Search | IOVS | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Andreas Stahl; Sandra Liakopoulos; Katrin Lorenz; Claudia Quiering; Laureen Sander; Georg Spital; Gabriele E Lang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1734. doi:

ARVO Annual Meeting Abstract July 2019

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Katrin Lorenz; Gabriele E Lang; Andreas Stahl; Claudia Quiering; Laureen Sander; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2789. doi:

ARVO Annual Meeting Abstract July 2018

Reporting of safety events across anti-VEGF indications and the Pharmacovigilance approach: Findings from the non-interventional OCEAN study

Focke Ziemssen; Jessica Voegeler; Georg Spital; Sandra Liakopoulos; Steffen Schmitz-Valckenberg; Thomas Bertelmann

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):215. doi:

ARVO Annual Meeting Abstract June 2017

Influence of OCT-examination during ranibizumab treatment of AMD patients in a real-life setting (OCEAN study)

Frederic Gunnemann; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Sandra Liakopoulos; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):412. doi:

ARVO Annual Meeting Abstract June 2017

Dependency of BCVA and ranibizumab treatment frequency of DME patients in a real-life setting (OCEAN study)

Focke Ziemssen; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1904. doi:

ARVO Annual Meeting Abstract June 2017

Real-life effectiveness of Ranibizumab in RVO patients in a prospective, non-interventional trial over 12 months (OCEAN study)

Josep Callizo; Thomas Bertelmann; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Nicolas Feltgen; Sandra Liakopoulos; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3674. doi:

Genetics January 2017

Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort—Impact of Selected Deep Intronic Variants and Common SNPs

PDF

Heidi L. Schulz; Felix Grassmann; Ulrich Kellner; Georg Spital; Klaus Rüther; Herbert Jägle; Karsten Hufendiek; Philipp Rating; Cord Huchzermeyer; Maria J. Baier; Bernhard H. F. Weber; Heidi Stöhr

Invest. Ophthalmol. Vis. Sci.. 2017; 58(1):394-403. doi: https://doi.org/10.1167/iovs.16-19936

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

Two distinct phenotypes in the same family are caused by the Schiff base counterion mutation p.E113K in rhodopsin.

Marta Owczarek-Lipska; Charlotte Reiff; Georg Spital; Carsten Roeger; Hebke Hinz; Christoph Jüschke; Holger Thiele; Janine Altmüller; Peter Nürnberg; Romain Da Costa; John Neidhardt

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3141. doi:

ARVO Annual Meeting Abstract September 2016

Challenges in the diagnosis of autosomal recessive bestrophinopathy: additional case reports

Benedikt Book; Heidi Barbara Stoehr; Bernhard HF Weber; Georg Spital

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3146. doi:

ARVO Annual Meeting Abstract June 2015

Impact of decentration of SDOCT volume scans on retinal thickness measurements in diabetic macula edema in a phase III multicenter randomized controlled trial (RELATION)

Daniel Michels; Tina Schick; Jessica Voegeler; Claudia Weiss; Georg Spital; Gabriele Elisabeth Lang; Sandra Liakopoulos; RELATION

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1528. doi:

ARVO Annual Meeting Abstract June 2015

Baseline visual acuity predicts visual acuity gain in Patients with Diabetic Macular Edema Following Anti-VEGF Treatment

Jost Hillenkamp; Georg Spital; Andreas Wenzel; Philippe Margaron; Jessica Voegeler

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1768. doi:

ARVO Annual Meeting Abstract April 2014

High visual acuity response with reduced number of ranibizumab injections in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

Philippe Margaron; Clare Bailey; Georg Spital; James Warburton; Ronny Hashmonay

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1705. doi:

ARVO Annual Meeting Abstract June 2013

Double-Masked Trial Demonstrates Superiority Of Combined Ranibizumab Plus Laser Versus Laser In Patients With Diabetic Macular Edema With Or Without Proliferative Diabetic Retinopathy

Chris Lohmann; Jessica Voegeler; Sandra Liakopoulos; Peter Wiedemann; Georg Spital; Gabriele Lang; RELATION STUDY GROUP

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1239. doi:

ARVO Annual Meeting Abstract March 2012

Dexamethasone Intravitreal Implant (Ozurdex®) In Patients With Macular Edema Due To Retinal Vein Occlusion

Mathias M. Maier; Thomas Groneberg; Nikolaus Feucht; Carsten H. Meyer; Georg Spital; Joachim Wachtlin; Lars O. Hattenbach; Nicolas Feltgen; Chris P. Lohmann

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):920. doi:

ARVO Annual Meeting Abstract April 2011

Results Of Prn-regimen In Anti-vegf Therapy For Amd In Clinical Practice

Britta E. Heimes; Albrecht Lommatzsch; Matthias Gutfleisch; Martha Dietzel; Meike Zeimer; Georg Spital; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):113. doi:

ARVO Annual Meeting Abstract April 2009

Funktional and Morphological Results of Anti-VEGF Treatment of Vascularized Pigment Epithelial Detachment

A. P. Lommatzsch; B. Heimes; G. Spital; M. Gutfleisch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1889. doi:

ARVO Annual Meeting Abstract May 2008

Prognostic Factors in Anti-VEGF Therapy in AMD

D. Pauleikhoff; B. Heimes; M. Dietzel; M. Zeimer; G. Spital; A. Lommatzsch; A. C. Bird

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2885. doi:

ARVO Annual Meeting Abstract May 2008

Retinal Pigment Epithelial Cells are Impaired by Complement

S. Wasmuth; M. Hennig; K. Lück; M. Zeimer; G. Spital; A. Lommatzsch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5153. doi:

ARVO Annual Meeting Abstract May 2004

Fundus Autofluorescence Imaging of Pigment Epithelial Detachments

F. Roth; A. Bindewald; J. Dolar–Szczasny; G. Spital; J. Mackiewicz; D. Pauleikhoff; F.G. Holz

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2962. doi:

ARVO Annual Meeting Abstract May 2004

Correlation of optical coherence tomography with fluorescein and indocyanine green angiography characteristics in patients with exudative age– related macular degeneration.

C. Gerth; G. Spital; I. Kroemer; A. Lommatzsch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3074. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Reporting of safety events across anti-VEGF indications and the Pharmacovigilance approach: Findings from the non-interventional OCEAN study

Influence of OCT-examination during ranibizumab treatment of AMD patients in a real-life setting (OCEAN study)

Dependency of BCVA and ranibizumab treatment frequency of DME patients in a real-life setting (OCEAN study)

Real-life effectiveness of Ranibizumab in RVO patients in a prospective, non-interventional trial over 12 months (OCEAN study)

Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort—Impact of Selected Deep Intronic Variants and Common SNPs

Two distinct phenotypes in the same family are caused by the Schiff base counterion mutation p.E113K in rhodopsin.

Challenges in the diagnosis of autosomal recessive bestrophinopathy: additional case reports

Impact of decentration of SDOCT volume scans on retinal thickness measurements in diabetic macula edema in a phase III multicenter randomized controlled trial (RELATION)

Baseline visual acuity predicts visual acuity gain in Patients with Diabetic Macular Edema Following Anti-VEGF Treatment

High visual acuity response with reduced number of ranibizumab injections in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

Double-Masked Trial Demonstrates Superiority Of Combined Ranibizumab Plus Laser Versus Laser In Patients With Diabetic Macular Edema With Or Without Proliferative Diabetic Retinopathy

Dexamethasone Intravitreal Implant (Ozurdex®) In Patients With Macular Edema Due To Retinal Vein Occlusion

Results Of Prn-regimen In Anti-vegf Therapy For Amd In Clinical Practice

Funktional and Morphological Results of Anti-VEGF Treatment of Vascularized Pigment Epithelial Detachment

Prognostic Factors in Anti-VEGF Therapy in AMD

Retinal Pigment Epithelial Cells are Impaired by Complement

Fundus Autofluorescence Imaging of Pigment Epithelial Detachments

Correlation of optical coherence tomography with fluorescein and indocyanine green angiography characteristics in patients with exudative age– related macular degeneration.

To View More...

You must be signed into an individual account to use this feature.